0
0
9/14/23 at 10:05pm
Organization
Hcplive.com
Author
Connor Iapoce
34 words
0
Comments
Factors including a longer diabetes duration and lower eGFR were associated with suboptimal treatment response to aflibercept in patients with DME.
You are the first to view
https://www.hcplive.com/view/systemic-ocular-risk-factors-predict-treatment-aflibercept-dme
Create an account
or login to join the discussion